Mechanism of amyloidogenesis: Nucleation-dependent fibrillation versus double-concerted fibrillation

BMB Reports

Volumn 42, Issue 9, 2009, Pages 541-551

  Bhak, Ghibom ^a   Choe, Young Jun ^a   Paik, Seung R ^a  

^a Seoul National University   (South Korea)

Author keywords

Amyloidogenesis; Fibrillar polymorphism; Nucleationdependent fibrillation; Protein self assembly; Template dependent and template independent fibrillations

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID;

ALZHEIMER DISEASE; AMYLOIDOSIS; CHEMISTRY; HUMAN; METABOLISM; PARKINSON DISEASE; REVIEW;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID; AMYLOIDOSIS; HUMANS; PARKINSON DISEASE;

EID: 70449702059     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2009.42.9.541     Document Type: Short Survey

References (117)

1. Sipe, J. D. (1992) Amyloidosis. Annu. Rev. Biochem. 61, 947-975.
2. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366.
3. Virchow, R. (1854) Zur celluslose-frage. Virchows Arch. 6, 415-426.
4. Selkoe, D. J. (2003) Folding proteins in fatal ways. Nature 426, 900-904.
5. Sacchettini, J. C. and Kelly, J. W. (2002) Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug. Discov. 1, 267-275.
6. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
7. Tan, S. Y. and Pepys, M. B. (1994) Amyloidosis. Histopathology 25, 403-414.
8. Merlini, G. and Bellotti, V. (2003) Molecular mechanisms of amyloidosis. N. Engl. J. Med. 349, 583-596.
9. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. and Lansbury, P. T. Jr. (2002) Amyloid pores from pathogenic mutations. Nature 418, 291.
10. Caughey, B. and Lansbury, P. T. Jr. (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267-298.
11. Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E. and Bush, A. I. (1999) Cu(II) potentiation of Alzheimer Ab neurotoxicity. J. Biol. Chem. 274, 37111-37116.
12. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E. and Bush, A. I. (1999) The Ab peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609-7616.
13. Cuajungco, M. P., Goldstein, L. E., Nunomura, A., Smith, M. A., Lim, J. T., Atwood, C. S., Huang, X., Farrag, Y. W., Perry, G. and Bush, A. I. (2000) Evidence that the b-amyloid plaques of Alzhermer's disease represent the redox-silencing and entombment of Ab by zinc. J. Biol. Chem. 275, 19439-19442.
14. Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C. and Bush, A. I. (2002) Metalloenzyme-like activity of Alzheimer's disease β-amyloid. J. Biol. Chem. 277, 40302-40308.
15. Barnham, K. J., Ciccotosto, G. D., Tickler, A. K., Ali, F. E., Smith, D. G., Williamson, N. A., Lam, Y. -H., Carrington, D., Tew, D., Kocak, G., Volitakis, I., Separovic, F., Barrow, C. J., Wade, J. D., Masters, C. L., Cherny, R. A., Curtain, C. C., Bush, A. I. and Cappai, R. (2003) Neurotoxic, redox-competent Alzheimer's b-amyloid is released from lipid membrane by methionine oxidation. J. Biol. Chem. 278, 42959-42965.
16. Fowler, D. M., Koulov, A. V., Balch, W. E. and Kelly, J. W. (2007) Functional amyloid - from bacteria to humans. Trends Biochem. Sci. 32, 217-224.
17. Barnhart, M. M. and Chapman, M. R. (2006) Curli biogenesis and function. Annu. Rev. Microbiol. 60, 131-147.
18. Costerton, J. W., Stewart, P. S. and Greenberg, E. P. (1999) Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322.
19. Kikuchi, T., Mizunoe, Y., Takade, A., Naito, S. and Yoshida, S. (2005) Curli fibers are required for development of biofilm architecture in Escherichia coli K-12 and enhance bacterial adhearence to human uroepithelial cells. Microbiol. Immunol. 49, 875-884.
20. Gebbink, M. F. B. G., Claessen, D., Bouma, B., Dijkhuizen, L. and Wösten, H. A. B. (2005) Amyloids - a functional coat for microorganisms. Nat. Rev. Microbiol. 3, 333-341.
21. Talbot, N. J. (2003) Aerial morphogenesis: enter the chaplins. Curr. Biol. 13, R696-R698.
22. Iconomidou, V. A., Vriend, G. and Hamodrakas, S. J. (2000) Amyloids protect the silkmoth oocyte and embryo. FEBS Lett. 479, 141-145.
23. Podrabsky, J. E., Carpenter, J. F. and Hand, S. C. (2001) Survival of water stress in annual fish embryos: dehydration avoidance and egg envelope amyloid fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R123-R131.
24. Fowler, D. M., Koulov, A. V., Alory-Jost, C., Marks, M. S., Balch, W. E. and Kelly, J. W. (2006) Functional amyloid formation within mammalian tissue. PLoS Biol. 4, e6.
25. Shibayama, Y., Joseph, K., Nakazawa, Y., Ghebreihiwet, B., Peerschke, E. I. B. and Kaplan, A. P. (1999) Zinc-dependent activation of the plasma kinin-forming cascade by aggregated β?amyloid protein. Clin. Immunol. 90, 89-99.
26. Sunde, M. and Blake, C. C. F. (1998) From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q. Rev. Biophys. 31, 1-39.
27. Sunde, M., Serpella, L. C., Bartlama, M., Frasera, P. E., Pepysa, M. B. and Blake, C. C. F. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273, 729-739.
28. Knowles, T. P., Fitzpatrick, A. W., Meehan, S., Mott, H. R., Vendruscolo, M., Dobson, C. M. and Welland, M. E. (2007) Role of intermolecular forces in defining material properties of protein nanofibrils. Science 318, 1900-1903.
29. Cherny, I. and Gazit, E. (2008) Amyloids: Not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed. 47, 4062-4069.
30. Zhang, S. (2003) Fabrication of novel biomaterials through molecular self-assembly. Nat. Biotechnol. 21, 1171-1178.
31. Scheibel, T., Parthasarathy, R., Sawicki, G., Lin, X. -M., Jaeger, H. and Lindquist, S. L. (2003) Conducting nanowires built by controlled self-assembly of amyloid fibers and selective metal deposition. Proc. Natl. Acad. Sci. U.S.A. 100, 4527-4532.
32. Song, Y., Challa, S. R., Medforth, C. J., Qiu, Y., Watt, R. K., Peña, D., Miller, J. E., Swol, F. and Shelnutt, J. A. (2004) Synthesis of peptide-nanotube platinum-nanoparticle composites. Chem. Commun. 1044-1045.
33. Reches, M. and Gazit, E. (2003) Casting metal nanowires within discrete self-assembled peptide nanotubes. Science 300, 625-627.
34. Carny, O., Shalev, D. E. and Gazit, E. (2006) Fabrication of coaxial metal nanocables using a self-assembled peptide nanotube scaffold. Nano Lett. 6, 1594-1597.
35. Fu, X., Wang, Y., Huang, L., Sha, Y., Gui, L., Lai, L. and Tang, Y. (2003) Asseblies of metal nanoparticles and self-assembled peptide fibrils - formation of double helical and single-chain arrays of metal nanoparticles. Adv. Mater. 15, 902-906.
36. Reches, M. and Gazit, E. (2007) Biological and chemical decoration of peptide nanostructures via biotin-avidin interactions. J. Nanosci. Nanotechnol. 7, 2239-2245.
37. Baxa, U., Speransky, V., Steven, A. C. and Wickner, R. B. (2002) Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc. Natl. Acad. Sci. U.S.A. 99, 5253-5260.
38. Baldwin, A. J., Bader, R., Christodoulou, J., MacPhee, C. E., Dobson, C. M. and Barker, P. D. (2006) Cytochrome display on amyloid fibrils. J. Am. Chem. Soc. 128, 2162-2163.
39. Corrigan, A. M., Müller, C. and Krebs, M. R. H. (2006) The formation of nematic liquid crystal phases by hen lysozyme amyloid fibrils. J. Am. Chem. Soc. 128, 14740-14741.
40. Aggeli, A., Bell, M., Boden, N., Keen, J. N., Knowles, P. F., McLeish, T. C. B., Pitkeathly, M. and Radford, S. E. (1997) Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes. Nature 386, 259-262.
41. Zhang, Y., Gu, H., Yang, Z. and Xu, B. (2003) Supramolecular hydrogels respond to lignad-receptor interaction. J. Am. Chem. Soc. 125, 13680-13681.
42. Yang, Z., Liang, G., Wang, L. and Xu, B. (2006) Using a kinase/phosphatase switch to regulate a supramolecular hydrogel and forming the supramolecular hydrogel in vivo. J. Am. Chem. Soc. 128, 3038-3043.
43. Conway, K. A., Harper, J. D. and Lansbury, P. T. Jr. (1998) Accelerated in vitro fibril formation by a mutant a-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318-1320.
44. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A. and Lansbury, P. T. Jr. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709-13715.
45. Kayed, R., Bernhagen, J., Greenfield, N., Sweimeh, K., Brunner, H., Voelter, W. and Kapurniotu, A. (1999) Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287, 781-796.
46. Teplow, D. B. (1998) Structural and kinetic features of amyloid b-protein fibrillogenesis. Amyloid: Int. J. Exp. Clin. Invest. 5, 121-142.
47. Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J. and Teplow, D. B. (1999) Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945-25952.
48. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. and Goedert, M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies form Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95, 6469-6473.
49. Spillantini, M. G., Schmidt, M. L., Lee, V. M. -Y., Trojanowski, J. Q., Jakes, R. and Goedert, M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839-840.
50. Recchia, A., Debetto, P., Negro, A., Guidolin, D., Skaper, S. D. and Giusti, P. (2004) a-Synuclein and Parkinson's disease. FASEB 18, 617-626.
51. Goedert, M. (2001) Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492-501.
52. Fink, A. L. (2006) The aggregation and fibrillation of α-synuclein. Acc. Chem. Res. 39, 628-634.
53. Jaikaran, E. T. A. S. and Clark, A. (2001) Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim. Biophys. Acta-Mol. Basis Dis. 1537, 179-203.
54. Hardy, J. A. and Higgins, G. A. (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256, 184-185.
55. Chiti, F. and Dobson, C. M. (2009) Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 5, 15-22.
56. Harris, D. A. and True, H. L. (2006) New insights into prion structure and toxicity. Neuron 50, 353-357.
57. Bernier, G. M. (1980) b2-Microglobulin: structure, function and significance. Vox Sanguinis. 38, 323-327.
58. Trinh, C. H., Smith, D. P., Kalverda, A. P., Phillips, S. E. V. and Radford, S. E. (2002) Crystal structure of monomeric human β-2-microglobulin reveals clues to its amyloidogenic properties. Proc. Natl. Acad. Sci. U.S.A. 99, 9771-9776.
59. Artymiuk, P. J. and Blake, C. C. F. (1981) Refinement of human lysozyme at 1.5 Å resoution analysis of nonbonded and hydrogen-bond interactions. J. Mol. Biol. 152, 737-762.
60. Blake, C. C. F., Koenig, D. F., Mair, G. A., North, A. C. T., Phillips, D. C. and Sarma, V. R. (1965) Structure of hen egg-white lysozyme: a three-dimensional fourier synthesis at 2 Å resolution. Nature 206, 757-761.
61. Kelly, J. W., Colon, W., Lai, Z., Lashuel, H. A., McCulloch, J., McCutchen, S. L., Miroy, G. J. and Peterson, S. A. (1997) Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv. Protein. Chem. 50, 161-181.
62. Bellotti, V., Mangione, P. and Merlini, G. (2000) Review: Immunoglobulin light chain amyloidosis - The archetype of structural and pathogenic variability. J. Struct. Biol. 130, 280-289.
63. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383.
64. Koch, K. M. (1992) Dialysis-related amyloidosis. Kidney Int. 41, 1416-1429.
65. Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C. F., Terry, C. J., Feest, T. G., Zalin, A. M. and Hsuan, J. J. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362, 553-557.
66. Teale, F. W. J. (1959) Cleavage of the haem-protein link by acid methylethylketone. Biochim. Biophys. Acta. 35, 543.
67. Fändrich, M., Fletcher, M. A. and Dobson, C. M. (2001) Amyloid fibrils from muscle myoglobin. Nature 410, 165-166.
68. Fändrich, M., Forge, V., Buder, K., Kittler, M., Dobson, C. M. and Diekmann, S. (2003) Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc. Natl. Acad. Sci. U.S.A. 100, 15463-15468.
69. Kodali, R. and Wetzel, R. (2007) Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. Struct. Biol. 17, 48-57.
70. Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W. -M., Mattson, M. P. and Tycko, R. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307, 262-265.
71. Wetzel, R., Shivaprasad, S. and Williams, A. D. (2007) Plasticity of amyloid fibrils. Biochemistry 46, 1-10.
72. Goldsbury, C., Frey, P., Olivieri, V., Aebi, U. and Müller, S. A. (2005) Multiple assembly pathways underlie amyloid-b fibril polymorphisms. J. Mol. Biol. 352, 282-298.
73. Gosal, W. S., Morten, I. J., Hewitt, E. W., Smith, D. A., Thomson, N. H. and Radford, S. E. (2005) Competing pathways determine fibril morphology in the self-assembly of b2-microglobulin into amyloid. J. Mol. Biol. 351, 850-864.
74. Griffith, J. S. (1967) Self-replication and scrapie. Nature 215, 1043-1044.
75. Nuvolone, M., Aguzzi, A. and Heikenwalder, M. (2009) Cells and prions: a license to replicate. FEBS Lett. 583, 2674-2684.
76. Park, J. -W., Ahn, J. S., Lee, J. -H., Bhak, G., Jung, S. and Paik, S. R. (2008) Amyloid fibrillar meshwork formation of ion-induced oligomeric species of Aβ40 with phthalocyanine tetrasulfonate and its toxic consequences. Chem. Bio. Chem. 9, 2602-2605.
77. Kim, Y. -S., Lee, D., Lee, E. -K., Sung, J. Y., Chung, K. C., Kim, J. and Paik, S. R. (2001) Multiple ligand interaction of a-synuclein produced various forms of protein aggregates in the presence of Aβ25-35, copper, and eosin. Brain Res. 908, 93-98.
78. Paik, S. R., Lee, D., Cho, H. -J., Lee, E. -N. and Chang, C. -S. (2003) Oxidized glutathione stimulated the amyloid formation of a-synuclein. FEBS Lett. 537, 63-67.
79. Lee, D., Lee, E. -K., Lee, J. -H., Chang, C. -S. and Paik, S. R. (2001) Self-oligomerization and protein aggregation of a-synuclein in the presence of coomassie brilliant blue. Eur. J. Biochem. 268, 295-301.
80. McLaurin, J., Yang, D. -S., Yip, C. M. and Fraser, P. E. (2000) Review: modulating factors in amyloi-b fibril formation. J. Struct. Biol. 130, 259-270.
81. Dong, J., Canfield, J. M., Mehta, A. K., Shokes, J. E., Tian, B., Childers, W. S., Simmons, J. A., Mao, Z., Scott, R. A., Warncke, K. and Lynn, D. G. (2007) Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity. Proc. Natl. Acad. Sci. U.S.A. 104, 13313-13318.
82. Koppaka, V. and Axelsen, P. H. (2000) Accelerated accumulation of amyloid b proteins on oxidatively damaged lipid membranes. Biochemistry 39, 10011-10016.
83. Naiki, H. and Gejyo, F. (1999) Kinetic analysis of amyloid fibril formation. Methods Enzymol. 309, 305-318.
84. Jarrett, J. T. and Lansbury, P. T. Jr. (1993) Seeding "onedimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
85. Harper, J. D. and Lansbury, P. T. Jr. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385-407.
86. Wood, S. J., Wypych, J., Steavenson, S., Louis, J. -C., Citron, M. and Biere, A. L. (1999) α-Synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J. Biol. Chem. 274, 509-512.
87. Sandal, M., Valle, F., Tessari, I., Mammi, S., Bergantino, E., Musiani, F., Brucale, M., Bubacco, L. and Samori, B. (2008) Conformational equilibria in monomeric α-synuclein at the single-molecule level. PLoS Biol. 6, e6.
88. Uversky, V. N., Lee, H. -J., Li, J., Fink, A. L. and Lee, S. -J. (2001) Stabilization of partially folded conformation during a-synuclein oligomerization in both purified and cytosolic preparations. J. Biol. Chem. 276, 43495-43498.
89. Bennett, M. J., Schlunegger, M. P. and Eisenberg, D. (1995) 3D domain swapping: a mechanism for oligomer assembly. Protein Sci. 4, 2455-2468.
90. Serio, T. R., Cashikar, A. G., Kowal, A. S., Sawicki, G. J., Moslehi, J. J., Serpell, L., Arnsdorf, M. F. and Lindquist, S. L. (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317-1321.
91. Li, J., Uversky, V. N. and Fink, A. L. (2001) Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein. Biochemistry 40, 604-613.
92. Uversky, V. N., Li, J. and Fink, A. L. (2001) Evidence for a partially folded intermediate in α-synuclein fibril formation. J. Biol. Chem. 276, 10737-10744.
93. Uversky, V. N., Li, J. and Fink, A. L. (2001) Pesticides directly accelerate the rate of α-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett. 500, 105-108.
94. Uversky, V. N., Li, J. and Fink, A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276, 44284-44296.
95. Carulla, N., Caddy, G. L., Hall, D. R., Zurdo, J., Gairi, M., Feliz, M., Giralt, E., Robinson, C. V. and Dobson, C. M. (2005) Molecular recycling within amyloid fibrils. Nature 436, 554-558.
96. Apetri, M. M., Maiti, N. C., Zagorski, M. G., Carey, P. R. and Anderson, V. E. (2006) Secondary structure of a-synuclein oligomers: characterization by Raman and atomic force microscopy. J. Mol. Biol. 355, 63-71.
97. Conway, K. A., Lee, S. -J., Rochet, J. -C., Ding, T. T., Williamson, R. E. and Lansbury, P. T. Jr. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both a-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. U.S.A. 97, 571-576.
98. Ding, T. T., Lee, S. -J., Rochet, J. -C. and Lansbury, P. T. Jr. (2002) Annular a-synuclein protofibrils are produced when spherical protofibrils are incubated in solution of bound to brain-derived membranes. Biochemistry 41, 10209-10217.
99. Hoyer, W., Cherny, D., Subramaniam, V. and Jovin, T. M. (2004) Rapid self-assembly of a-synuclein observed by in situ atomic force microscopy. J. Mol. Biol. 340, 127-139.
100. Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B. and Teplow, D. B. (2003) Amyloid b-protein (Ab) assembly: Ab40 and Ab42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U.S.A. 100, 330-335.
101. Jain, S. and Udgaonkar, J. B. (2008) Evidence for stepwise formation of amyloid fibrils by the mouse prion protein. J. Mol. Biol. 382, 1228-1241.
102. Eakin, C. M., Attenello, F. J., Morgan, C. J. and Miranker, A. D. (2004) Oligomeric assembly of native-like precursors precedes amyloid formation by β-2 microglobulin. Biochemistry 43, 7808-7815.
103. Modler, A. J., Gast, K., Lutsch, G. and Damaschun, G. (2003) Assembly of amyloid protofibrils via critical oligomers - A novel pathway of amyloid formation. J. Mol. Biol. 325, 135-148.
104. Leonil, J., Henry, G., Jouanneau, D., Delage, M. -M., Forge, V. and Putaux, J. -L. (2008) Kinetics of fibril formation of bovine k-casein indicate a conformational rearrangement as a critical step in the process. J. Mol. Biol. 381, 1267-1280.
105. Cheon, M., Chang, I., Mohanty, S., Luheshi, L. M., Dobson, C. M., Vendruscolo, M. and Favrin, G. (2007) Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput. Biol. 3, 1727-1738.
106. Bhak, G., Lee, J. -H., Hahn, J. -S. and Paik, S. R. (2009) Granular assembly of a-synuclein leading to the accelerated amyloid fibril formation with shear stress. PLoS ONE 4, e4177.
107. Lee, J. -H., Bhak, G., Lee, S. -G. and Paik, S. R. (2008) Instantaneous amyloid fibril formation of a-synuclein from the oligomeric granular structures in the presence of hexane. Biophys. J. 95, L16-L18.
108. Vestergaard, B., Groenning, M., Roessle, M., Kastrup, J. S., Weert, M., Flink, J. M., Frokjaer, S., Gajhede, M. and Svergun, D. I. (2007) A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol. 5, e134.
109. Bates, G. (2003) Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361, 1642-1644.
110. Morozova-Roche, L. A., Zamotin, V., Malisauskas, M., Öhman, A., Chertkova, R., Lavrikova, M. A., Kostanyan, I. A., Dolgikh, D. A. and Kirpichnikov, M. P. (2004) Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways. Biochemistry 43, 9610-9619.
111. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W. and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
112. Kaylor, J., Bodner, N., Edridge, S., Yamin, G., Hong, D. -P. and Fink, A. L. (2005) Characterization of oligomeric intermediates in a-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F α-synuclein. J. Mol. Biol. 353, 357-372.
113. Kumar, S. and Udgaonkar, J. B. (2009) Conformational conversion may precede or follow aggregate elongation on alternative pathways of amyloid protofibril formation. J. Mol. Biol. 385, 1266-1276.
114. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E. and Glabe, C. G. (2004) Permeabilization of lipid bilayers is a common conformationdependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366.
115. Souillac, P. O., Uversky, V. N. and Fink, A. L. (2003) Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN. Biochemistry 42, 8094-8104.
116. Bader, R., Bamford, R., Zurdo, J., Luisi, B. F. and Dobson, C. M. (2006) Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation. J. Mol. Biol. 356, 189-208.
117. Quintas, A., Vaz, D. C., Cardoso, I., Saraiva, M. J. M. and Brito, R. M. M. (2001) Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J. Biol. Chem. 276, 27207-27213.